Markers for HIV-disease progression in untreated patients and patients receiving AZT: Evaluation of viral activity, AZT resistance, serum cholesterol, β2-microglobulin, CD4+ cell counts, and HIV antigen H. Rübsamen-WaigmannB. SchröderU. Dietrich OriginalPaper Pages: S77 - S82
Serological markers as prognostic criteria for the course of HIV infection A. KleinschmidtA. MatuschkeR. Hehlmann OriginalPaper Pages: S89 - S92
Tumor necrosis factor and interferon as prognostic markers in human immunodeficiency virus (HIV) infection G. HessS. RossolK. -H. Meyer zum Büschenfelde OriginalPaper Pages: S93 - S97
Neopterin and β2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection D. FuchsA. KrämerH. Wachter OriginalPaper Pages: S98 - S102
Lymphocyte subsets as surrogate markers in antiretroviral therapy J. R. BognerF. -D. Goebel OriginalPaper Pages: S103 - S108